• Corpus ID: 8153987

Can psychedelic drugs play a role in palliative care ?

  title={Can psychedelic drugs play a role in palliative care ?},
  author={Spir i tual},
Psychedelic drugs are agents that may assist a person in approaching existential issues. They enjoy a rich history in ancient, non-Western cultures and, more recently, in psychiatric research of the 1960s. After a 40-year hiatus, international trials are now underway to revisit the role of psychedelic drugs in assisting patients with terminal cancer to explore – and resolve – anxiety-inducing existential issues surrounding their illness. 
Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry
  • B. Sessa
  • Psychology, Medicine
    Journal of psychoactive drugs
  • 2014
Without researching psychedelic drugs for medical therapy, psychiatry is turning its back on a group of compounds that could have great potential and can provide the public with important treatments and also raise the profile of expanded consciousness in mainstream society.
Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
LSD and psilocybin are generally safe if administered by a healthcare professional, although further investigations are needed to assess their utility for patients with persistent pain, especially associated with terminal illness.
Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care
Evidence-based knowledge surrounding this potentially sensitive topic is necessary to invite understanding, promote scientific knowledge development, and create healing environments for patients, nurses, and researchers alike.
Lysergic acid diethylamide: a drug of ‘use’?
The receptor pharmacology, mechanism of action, effects and adverse effects of LSD on the normal body system are described, and its addictive potentials and the chances of developing tolerance are highlighted.
Turismo y chamanismo, dos mundos imbricados: el caso de Huautla de Jiménez, Oaxaca
Since the 1960s, two worlds that were thought to be without connection: tourism and shamanism, have become intertwined through information and movement flows such as in the case of Huautla de Jimenez


Can psychedelics have a role in psychiatry once again?
  • B. Sessa
  • Psychology
    The British journal of psychiatry : the journal of mental science
  • 2005
Psychedelic or hallucinogenic drugs such as lysergic acid diethylamide (LSD), 3,4,5-trimethoxy-β-phenethylamine (mescaline), psilocybin, 3,4-methylenedioxymethamphetamine (MDMA),
Is there a case for MDMA-assisted psychotherapy in the UK?
  • B. Sessa
  • Psychology
    Journal of psychopharmacology
  • 2007
The author asks that the medical profession consider a dispassionate and open-minded debate to examine whether MDMA might have a legitimate place as an adjunct to psychotherapy in modern psychiatric practice.
Can drugs be used to enhance the psychotherapeutic process?
Many preindustrial cultures traditionally use certain psychedelic plants to enhance a procedure that resembles psychotherapy--an idea that was also tested in Western psychiatry in the 1950s and
The Therapeutic Use of MDMA
Results from 80 patients indicate that MDMA seems to decrease the fear response to a perceived threat to a patient’s emotional integrity, leading to a corrective emotional experience that probably diminishes the pathological effects of previous traumatic experiences.
Study of Lysergic Acid Diethylamide as an Analgesic Agent
This report explored the analgesic action of lysergic acid diethylamide (LSD25), an ergot derivative which has a number of psychic effects in humans.
Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide
  • E. Kast
  • Medicine, Psychology
    The Psychiatric quarterly
  • 1967
The analgesic action of LSD is further confirmed, the relative safety of the drug for that use is demonstrated, and further study is recommended.
Adjuvant psychological therapy for patients with cancer: Outcome at one year
It is demonstrated that a brief psychological intervention can produce improvement in psychological functioning which persists up to 10 months after the end of the intervention; in particular, the number of patients who would still meet criteria for ‘caseness’ is reduced.
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
When administered under supportive conditions, psilocybin occasioned experiences similar to spontaneously occurring mystical experiences, and the ability to occasion such experiences prospectively will allow rigorous scientific investigations of their causes and consequences.
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study
PY affects core dimensions of altered states of consciousness and physiological parameters in a dose-dependent manner and provided no cause for concern that PY is hazardous with respect to somatic health.